Huiyu Pharmaceutical announced that the company received the 'Notification of Approval for Drug Clinical Trials' issued by the National Medical Products Administration, and the clinical trial application for the self-developed HY-2003 has been approved.
汇宇制药：公司自主研发的HY-2003临床试验申请获得批准
Huiyu Pharmaceutical: The company's self-developed clinical trial application for HY-2003 has been approved.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated